SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-026785
Filing Date
2020-02-06
Accepted
2020-02-06 16:14:40
Documents
14
Period of Report
2020-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d855539d8k.htm   iXBRL 8-K 26511
2 EX-99.1 d855539dex991.htm EX-99.1 68207
6 GRAPHIC g855539g0206105205840.jpg GRAPHIC 3526
  Complete submission text file 0001193125-20-026785.txt   228467

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA enta-20200206.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20200206_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20200206_pre.xml EX-101.PRE 10948
8 EXTRACTED XBRL INSTANCE DOCUMENT d855539d8k_htm.xml XML 3258
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 20582860
SIC: 2834 Pharmaceutical Preparations